Trupanion (NASDAQ:TRUP) CEO Sells $10,733.26 in Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 491 shares of the company’s stock in a transaction dated Monday, May 25th. The shares were sold at an average price of $21.86, for a total transaction of $10,733.26. Following the completion of the transaction, the chief executive officer directly owned 176,379 shares in the company, valued at $3,855,644.94. The trade was a 0.28% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Trupanion Trading Down 1.5%

NASDAQ TRUP opened at $21.82 on Friday. The firm’s 50-day moving average is $24.92 and its two-hundred day moving average is $30.34. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $57.88. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. The stock has a market capitalization of $951.79 million, a P/E ratio of 36.98 and a beta of 1.49.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The company had revenue of $384.05 million for the quarter, compared to analysts’ expectations of $379.77 million. During the same quarter in the prior year, the company posted ($0.03) earnings per share. Trupanion’s revenue for the quarter was up 12.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Trupanion, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

TRUP has been the topic of a number of recent research reports. Weiss Ratings lowered shares of Trupanion from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, March 4th. Bank of America cut their price target on shares of Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research note on Tuesday, April 14th. Zacks Research lowered shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 13th. Piper Sandler cut their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research note on Friday, February 13th. Finally, Cantor Fitzgerald cut their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $42.25.

Institutional Trading of Trupanion

Large investors have recently made changes to their positions in the company. Millennium Management LLC increased its stake in Trupanion by 185.8% in the third quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after purchasing an additional 402,421 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Trupanion by 116.4% in the fourth quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock valued at $17,826,000 after purchasing an additional 256,559 shares during the last quarter. Two Sigma Investments LP increased its stake in Trupanion by 3,201.0% in the third quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock valued at $9,713,000 after purchasing an additional 217,634 shares during the last quarter. Polar Capital Holdings Plc increased its stake in Trupanion by 13.5% in the fourth quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock valued at $55,121,000 after purchasing an additional 175,000 shares during the last quarter. Finally, Marshall Wace LLP increased its stake in Trupanion by 15.5% in the third quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock valued at $52,462,000 after purchasing an additional 163,101 shares during the last quarter.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.